QR12000 Compound Tablets in Patients with Moderate to Severe Essential Hypertension
QR12000 Compound Tablets in Patients with Moderate to Severe Essential Hypertension
Not yet recruiting · NCT06716970 · Registry updated 2024-12-06Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| QR12000 Compound Tablets in Patients with Moderate to Severe Essential Hypertension | cardiovascular disorder, essential hypertension, hypertensive disorder, vascular disorder | Not yet recruiting | Phase 3 | 2024-12-06 | NCT06716970 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Wuhan Createrna Science and Technology Co., Ltd | 6 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Peking University First Hospital | Beijing | China | 163 |